0
Signin
countryflagUS

18889881171

AAPL 167.04 -0.5714% MSFT 404.33 -1.8235% GOOG 157.46 0.3697% GOOGL 155.9725 0.3232% AMZN 179.17 -1.1639% NVDA 846.71 0.7568% META 501.8 1.544% TSLA 149.9 -3.5703% TSM 132.27 -4.8623% LLY 745.95 -0.642% V 271.36 -0.4877% AVGO 1258.99 -1.8431% JPM 181.25 0.6497% UNH 493.18 2.9625% NVO 122.75 -1.4294% WMT 59.27 -0.637% LVMUY 170.18 -0.3338% XOM 118.47 -0.1349% LVMHF 854.0 -0.4662% MA 454.7 -1.1865%

Electrocore LLC

Healthcare US ECOR

5.64USD
0.05(0.98%)

Last update at 2024-04-18T20:00:00Z

Day Range

5.635.92
LowHigh

52 Week Range

3.107.50
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -22.59300M -18.06930M -24.68200M -45.12900M -55.76302M
Minority interest - - 0.64M 0.64M 0.64M
Net income -22.16200M -17.21810M -23.51110M -45.14700M -55.82046M
Selling general administrative 24.33M 21.57M 0.02M 35.42M 42.50M
Selling and marketing expenses - - - - -
Gross profit 6.98M 4.07M 1.76M 1.23M 0.41M
Reconciled depreciation 0.55M 0.38M 0.40M 0.25M 0.07M
Ebit -23.42200M -20.04310M -24.28390M -44.09100M -53.89210M
Ebitda -22.87400M -22.01450M -23.81930M -42.09400M -53.82544M
Depreciation and amortization 0.55M -1.97140M 0.46M 2.00M 0.07M
Non operating income net other - - 0.07M 0.96M -1.20950M
Operating income -22.87400M -20.04310M -24.28390M -44.09100M -54.55352M
Other operating expenses 31.47M 25.49M 27.78M 46.48M 55.55M
Interest expense 0.29M 4.33M 0.46M 2.79M 0.00000M
Tax provision -0.43100M -0.85117M -1.17089M 0.02M 0.00243M
Interest income 0.29M 0.01M 0.08M 0.97M 1.01M
Net interest income 0.29M 0.01M 0.08M 0.97M 1.01M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.43100M -0.85120M -1.17090M 0.02M 0.00243M
Total revenue 8.59M 5.45M 3.50M 2.39M 0.99M
Total operating expenses 29.85M 24.11M 26.04M 45.32M 54.97M
Cost of revenue 1.62M 1.39M 1.74M 1.16M 0.58M
Total other income expense net 0.28M 1.97M -0.39810M -1.03800M -2.21583M
Discontinued operations - - - - -
Net income from continuing ops -22.16200M -17.21807M -23.51105M -45.14788M -55.76546M
Net income applicable to common shares -22.16200M -17.21807M -23.51105M -45.14788M -34.70212M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 24.76M 42.83M 31.52M 36.10M 73.50M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.83M 1.05M 0.03M 1.09M 1.92M
Total liab 7.67M 6.18M 7.87M 10.56M 7.32M
Total stockholder equity 17.09M 36.65M 23.64M 24.90M 65.55M
Deferred long term liab - - - - 0.40M
Other current liab 4.69M 3.88M 2.80M 3.34M 4.37M
Common stock 0.00500M 0.07M 0.05M 0.03M 0.03M
Capital stock 0.00500M 0.07M 0.05M 0.03M 0.03M
Retained earnings -146.37000M -124.20822M -106.99015M -83.47910M -38.33122M
Other liab - - - 1.42M 0.25M
Good will - - - - -
Other assets 3.46M -0.00001M 4.89M 0.64M 0.42M
Cash 17.71M 34.69M 4.24M 13.56M 7.60M
Cash and equivalents - - - - -
Total current liabilities 7.04M 5.49M 5.89M 9.14M 7.07M
Current deferred revenue 0.15M - - - -
Net debt -17.01300M -33.92803M -1.24784M -11.54580M -7.60028M
Short term debt 0.07M 0.06M 1.01M 0.60M -
Short long term debt - - 0.48M 0.11M -
Short long term debt total 0.70M 0.76M 2.99M 2.02M -
Other stockholder equity 163.52M 160.77M 130.84M 108.39M -73400.54499M
Property plant equipment 0.61M 0.76M 0.24M 1.78M 0.38M
Total current assets 21.17M 37.54M 22.63M 26.53M 72.70M
Long term investments - - - - -
Net tangible assets 16.31M 36.13M 23.01M 23.18M 65.55M
Short term investments - 0.00000M 18.39M 10.50M 60.96M
Net receivables 0.40M 0.44M 0.27M 0.50M 0.27M
Long term debt - - 1.10M - -
Inventory 1.98M 1.36M 0.84M 0.89M 1.95M
Accounts payable 2.13M 1.54M 2.08M 5.21M 2.70M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - 0.64M 0.64M -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.06900M 0.01M -0.25147M -0.04129M 0.06M
Additional paid in capital - - - - -
Common stock total equity - - 0.05M 0.03M 0.03M
Preferred stock total equity - - - - -
Retained earnings total equity - - -106.99015M -83.47910M -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 2.97M 4.53M 8.13M 7.15M 0.42M
Deferred long term asset charges - - - - -
Non current assets total 3.58M 5.29M 8.89M 8.93M 0.81M
Capital lease obligations 0.70M 0.76M 1.42M 1.91M -
Long term debt total - - 1.10M - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 0.00000M 18.22M -7.96316M 51.04M -36.54891M
Change to liabilities 1.19M 0.46M -2.60459M 1.76M 2.91M
Total cashflows from investing activities - 18.22M -7.96316M 50.97M -36.82783M
Net borrowings - - 1.46M 0.11M 0.11M
Total cash from financing activities 0.00000M 25.68M 18.95M 0.16M 78.33M
Change to operating activities 0.52M 1.01M -1.18871M -0.17752M -0.36161M
Net income -22.16200M -17.21807M -23.51105M -45.14788M -55.76546M
Change in cash -16.72700M 30.45M -9.32185M 5.96M -5.62391M
Begin period cash flow 34.69M 4.24M 13.56M 7.60M 13.22M
End period cash flow 17.96M 34.69M 4.24M 13.56M 7.60M
Total cash from operating activities -16.64500M -13.62762M -20.10259M -45.06654M -47.11035M
Issuance of capital stock 0.00000M 25.68M 17.49M 0.00000M 78.33M
Depreciation 0.55M 0.38M 0.40M 0.25M 0.07M
Other cashflows from investing activities - - - 51.04M -36.54891M
Dividends paid - - - - 3629.09M
Change to inventory 0.30M 0.37M 0.74M -4.96177M -1.62162M
Change to account receivables 0.04M -0.21719M 0.23M -0.22854M -0.16439M
Sale purchase of stock - - - 0.05M 78.33M
Other cashflows from financing activities - 18.22M 2.56M 0.86M 3629.09M
Change to netincome 2.93M 1.58M 3.70M 3.97M 7.61M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.07M 0.28M
Change receivables - - 0.23M -0.22854M -0.16439M
Cash flows other operating - - 0.92M -0.18089M 0.35M
Exchange rate changes - - - - -0.02019M
Cash and cash equivalents changes - - -9.11388M 6.07M -5.62391M
Change in working capital 2.04M 1.63M -1.80906M -2.57010M -0.28909M
Stock based compensation 2.68M 3.30M 3.27M 3.90M 7.60M
Other non cash items 0.24M -0.01178M 0.53M -0.96382M -0.09562M
Free cash flow -16.64500M -13.62762M -20.10259M -45.13622M -47.38927M

Fundamentals

  • Previous Close 5.59
  • Market Cap33.37M
  • Volume5742
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-19.66100M
  • Revenue TTM13.40M
  • Revenue Per Share TTM2.66
  • Gross Profit TTM 7.21M
  • Diluted EPS TTM-4.11

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ECOR
Electrocore LLC		 0.05 0.98% 5.64 - - 2.49 3.02 1.53 -1.0105
ABT
Abbott Laboratories		 -0.63 0.59% 105.27 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation		 -8.58 2.55% 327.45 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 0.11 0.14% 79.19 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -0.54 0.79% 67.42 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

View All

Profile

electroCore, Inc., a commercial-stage bioelectronic medicine and wellness company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults; Truvaga for the support of general health and wellbeing; and TAC-STIM, a form of nVNS for human performance. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Electrocore LLC

200 Forge Way, Rockaway, NJ, United States, 07866

Key Executives

Name Title Year Born
Mr. Daniel S. Goldberger CEO & Director 1959
Mr. Joseph P. Errico Co-Founder, Principal Investor & Director 1969
Dr. Thomas J. Errico M.D. Founder, Independent Director & Principal Investor 1952
Mr. Brian M. Posner CFO & Corp. Sec. 1962
Mr. Michael Romaniw Exec. VP of Systems & Operations 1957
Ms. Jackie Dorsky VP of Marketing NA
Mr. Iain Strickland Ph.D. Sr. VP of Global Sales & Strategy NA
Ms. Carrie Kochek Sr. Director of HR NA
Dr. Peter S. Staats M.B.A., M.D. Chief Medical Officer 1963
Mr. Eric J. Liebler Sr. VP of Neurology 1964

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).